Home/Filings/4/A/0001062993-25-009904
4/A//SEC Filing

PISKEL KYLE 4/A

Accession 0001062993-25-009904

CIK 0001478320other

Filed

May 19, 8:00 PM ET

Accepted

May 20, 7:46 PM ET

Size

5.1 KB

Accession

0001062993-25-009904

Insider Transaction Report

Form 4/AAmended
Period: 2025-05-16
PISKEL KYLE
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2025-05-16$8.89/sh1,929$17,149269,581 total
Footnotes (1)
  • [F1]This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Issuer

Adaptive Biotechnologies Corp

CIK 0001478320

Entity typeother

Related Parties

1
  • filerCIK 0001780662

Filing Metadata

Form type
4/A
Filed
May 19, 8:00 PM ET
Accepted
May 20, 7:46 PM ET
Size
5.1 KB